| American Cosmetic Surgery Limited |
| Registered number: |
04108918 |
| Balance Sheet |
| as at 30 November 2024 |
|
| Notes |
|
|
2024 |
|
|
2023 |
| £ |
£ |
| Fixed assets |
| Tangible assets |
4 |
|
|
474,187 |
|
|
499,729 |
|
| Current assets |
| Stocks |
|
|
11,351 |
|
|
9,723 |
| Debtors |
5 |
|
715,023 |
|
|
680,492 |
| Cash at bank and in hand |
|
|
3,622,644 |
|
|
3,018,751 |
|
|
|
4,349,018 |
|
|
3,708,966 |
|
| Creditors: amounts falling due within one year |
6 |
|
(527,777) |
|
|
(321,292) |
|
| Net current assets |
|
|
|
3,821,241 |
|
|
3,387,674 |
|
| Total assets less current liabilities |
|
|
|
4,295,428 |
|
|
3,887,403 |
|
| Creditors: amounts falling due after more than one year |
7 |
|
|
(37,500) |
|
|
(87,500) |
|
|
|
| Net assets |
|
|
|
4,257,928 |
|
|
3,799,903 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
4,257,828 |
|
|
3,799,803 |
|
| Shareholder's funds |
|
|
|
4,257,928 |
|
|
3,799,903 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The member has not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| Dr Ioannis Kosmas Alexandrides |
| Director |
| Approved by the board on 4 December 2025 |
|
| American Cosmetic Surgery Limited |
| Notes to the Accounts |
| for the year ended 30 November 2024 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Leasehold land and buildings |
Straight line basis over 5 years |
|
Plant and machinery |
15% on written down value |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
Provisions |
|
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. |
|
|
Leased assets |
|
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term. |
|
|
Pensions |
|
Contributions to defined contribution plans are expensed in the period to which they relate. |
|
|
| 2 |
Employees |
2024 |
|
2023 |
| Number |
Number |
|
|
Average number of persons employed by the company |
18 |
|
17 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Intangible fixed assets |
£ |
|
Goodwill: |
|
|
Cost |
|
At 1 December 2023 |
295,000 |
|
At 30 November 2024 |
295,000 |
|
|
|
|
|
|
|
|
|
|
Amortisation |
|
At 1 December 2023 |
295,000 |
|
At 30 November 2024 |
295,000 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 30 November 2024 |
- |
|
|
|
|
|
|
|
|
|
|
Goodwill is being written off in equal annual instalments over its estimated economic life of 5 years. |
|
|
| 4 |
Tangible fixed assets |
|
|
|
|
Land and buildings |
|
Plant and machinery etc |
|
Total |
| £ |
£ |
£ |
|
Cost |
|
At 1 December 2023 |
418,226 |
|
1,084,331 |
|
1,502,557 |
|
Additions |
37,667 |
|
31,638 |
|
69,305 |
|
At 30 November 2024 |
455,893 |
|
1,115,969 |
|
1,571,862 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 December 2023 |
307,169 |
|
695,659 |
|
1,002,828 |
|
Charge for the year |
32,850 |
|
61,997 |
|
94,847 |
|
At 30 November 2024 |
340,019 |
|
757,656 |
|
1,097,675 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 30 November 2024 |
115,874 |
|
358,313 |
|
474,187 |
|
At 30 November 2023 |
111,057 |
|
388,672 |
|
499,729 |
|
|
|
|
|
|
|
|
|
|
|
|
| 5 |
Debtors |
2024 |
|
2023 |
| £ |
£ |
|
|
SC 419 recoverable |
|
|
|
|
80,069 |
|
80,069 |
|
Director's loan account |
|
|
|
|
284,717 |
|
284,717 |
|
Other debtors |
350,237 |
|
315,706 |
|
|
|
|
|
|
715,023 |
|
680,492 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Creditors: amounts falling due within one year |
2024 |
|
2023 |
| £ |
£ |
|
|
Bank loans and overdrafts |
50,000 |
|
54,042 |
|
Trade creditors |
1,225 |
|
1,832 |
|
Corporation tax |
436,005 |
|
211,510 |
|
Other taxes and social security costs |
22,348 |
|
25,382 |
|
Other creditors |
18,199 |
|
28,526 |
|
|
|
|
|
|
527,777 |
|
321,292 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Creditors: amounts falling due after one year |
2024 |
|
2023 |
| £ |
£ |
|
|
Bank loans |
37,500 |
|
87,500 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Loans to directors |
|
Description and conditions |
B/fwd |
Paid |
Repaid |
C/fwd |
| £ |
£ |
£ |
£ |
|
Dr Ioannis Kosmas Alexandrides |
|
[Loan 1] |
284,717 |
|
- |
|
- |
|
284,717 |
|
|
|
284,717 |
|
- |
|
- |
|
284,717 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Other information |
|
|
American Cosmetic Surgery Limited is a private company limited by shares and incorporated in England. Its registered office is: |
|
111 Harley Street |
|
London |
|
W1G 6AW |
|
|
| 10 |
Controlling party |
|
|
The controlling party is Dr Ioannis Kosmas Alexandrides by virtue of his ownership of 100% of |
|
the issued ordinary share capital of the company as at 30 November 2024. |
|
|
On 31 October 2025, the controlling changed to Viannos Holdings Limited by virtue of it's |
| |
ownership of 100% of the issued share capital of the company. |